Related Experiment Video
Updated: Sep 1, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Reducing Thrombotic Risk From Polyvascular Disease in Primary Care
1Stephen Brunton, MD, FAAFP, Adjunct Associate Professor, Touro University California, College of Osteopathic Medicine, Vallejo, California.
Insights
This activity focuses on polyvascular disease, encompassing peripheral arterial disease (PAD) and coronary artery disease (CAD). It aims to improve the detection, risk assessment, and evidence-based treatment of patients with these conditions to reduce adverse events.
Area of Science:
- Cardiovascular Medicine
- Vascular Surgery
- Atherothrombosis Research
Background:
- Polyvascular disease, defined as the presence of both peripheral arterial disease (PAD) and coronary artery disease (CAD), significantly increases the risk of atherothrombotic events.
- Patients with PAD and CAD face a higher burden of disease and poorer prognosis compared to those with isolated disease.
- Accurate identification and comprehensive management are crucial for mitigating cardiovascular and limb-related complications.
Purpose of the Study:
- To enhance understanding of the disease burden and atherothrombotic risk in patients with polyvascular disease (PAD and CAD).
- To outline effective screening and diagnostic strategies for improved detection of polyvascular disease.
- To guide the selection of evidence-based treatments for reducing cardiovascular and limb events in this high-risk population.
Main Methods:
- Review of current literature and clinical guidelines on polyvascular disease management.
- Analysis of screening tools and diagnostic modalities for PAD and CAD.
- Evaluation of evidence supporting various therapeutic interventions for atherothrombotic risk reduction.
Main Results:
- Polyvascular disease represents a substantial atherothrombotic risk, necessitating integrated care approaches.
- Early detection through targeted screening improves the identification of patients with coexisting PAD and CAD.
- Multifaceted treatment strategies, including lifestyle modifications, pharmacotherapy, and revascularization, are essential for optimal outcomes.
Conclusions:
- Effective management of polyvascular disease requires a thorough understanding of its burden and risk factors.
- Implementing standardized screening and diagnostic protocols can lead to earlier and more accurate detection.
- Evidence-based therapeutic selection is key to reducing the incidence of cardiovascular and limb events in patients with PAD and CAD.
Learning Objectives:
At the end of the activity, participants will be able to:Describe the burden of disease and risk of atherothrombotic events in patients with polyvascular disease-peripheral arterial disease (PAD) and coronary artery disease (CAD). Implement screening and diagnostic procedures to improve detection of polyvascular disease and accurately assess overall atherothrombotic risk. Select evidence-based treatment to reduce cardiovascular and limb events in patients with polyvascular disease.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Atherosclerosis III: Management
Peripheral Artery Disease V: Postoperative Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins

